Manhattan Associates Powers Asda’s New ‘Game Changing’ Omni-channel Offering
Jan 11, 2016 14:00 pm UTC| Business
Manhattan provides technology for first-of-its-kind fulfillment and return service “toyou” LONDON and ATLANTA, Jan. 11, 2016 (GLOBE NEWSWIRE) -- Manhattan Associates, Inc. (NASDAQ:MANH) today announced its pivotal...
Inteliquent Expands Leadership Team, Hires Michelle Owczarzak as Senior Vice President, Sales
Jan 11, 2016 14:00 pm UTC| Business
CHICAGO, Jan. 11, 2016 (GLOBE NEWSWIRE) -- Inteliquent, Inc. (NASDAQ:IQNT), the carrier for communication service providers, announced today that its Board of Directors appointed Michelle Owczarzak as its Senior Vice...
LivaNova PLC Announces Approval of Perceval
Jan 11, 2016 14:00 pm UTC| Business
LONDON, Jan. 11, 2016 (GLOBE NEWSWIRE) -- LivaNova PLC (NASDAQ:LIVN) (LSE:LIVN) (the “Company”) announced that, on January 8, 2016, the Company received approval from the United States Food and Drug Administration...
Rexahn Pharmaceuticals’ Archexin® Shows Dose-Dependent Tumor Reduction in a Phase IIa Clinical Study
Jan 11, 2016 14:00 pm UTC| Business
ROCKVILLE, Md., Jan. 11, 2016 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE MKT:RNN), a clinical stage biopharmaceutical company developing next generation therapeutics for the treatment of cancer, announced...
MannKind Provides Update on Senior Management
Jan 11, 2016 14:00 pm UTC| Business
VALENCIA, Calif., Jan. 11, 2016 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD) (TASE:MNKD) today announced that MannKind has withdrawn its offer to employ Duane M. DeSisto as its President and Chief Executive...
Jan 11, 2016 14:00 pm UTC| Business
WASHINGTON, Jan. 11, 2016 (GLOBE NEWSWIRE) -- DuPont Fabros Technology, Inc. (NYSE:DFT), a leading owner, developer, operator and manager of enterprise-class, carrier-neutral, large multi-tenant wholesale data centers,...
Cellular Biomedicine Group Announces CEO Transition
Jan 11, 2016 14:00 pm UTC| Business
SHANGHAI, China and CUPERTINO, Calif., Jan. 11, 2016 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc. (NASDAQ:CBMG) (“CBMG” or the “Company”), a biomedicine firm engaged in the development of effective stem cell...